Basic Science Course Directors and Chairs, Selected Faculty and
Administrators,
I am writing to pass along some information about
enhancing/introducing molecular (genomic) medicine into the basic science
curriculum. As some of you know, I have been interested in this topic
having an increased role in our curriculum and am here proposing that we meet to
discuss this topic: its significance to modern medicine, the need for its
inclusion in the curriculum, and how it might be incorporated in an already
very tight schedule. In fact, it may require relatively small changes in
an appropriately integrated, but discipline-base curriculum as we have at
present.
This is a continuation of a discussion begun at the July, 2003 and
meeting of IAMSE (International Association of Medical Science
Educators). This year, Paul Monaco and I attended this meeting; I have
been attending the yearly meetings since 2001. At this meeting there were
three sessions dealing with molecular (genomic) medicine highlighting its
importance clinically and how it might be presented to medical students.
- Dr. David Valle,
Pediatrics at Johns Hopkins University Medical School, gave
a plenary session talk on Genetics,
Individuality and Re-Thinking of Medical Education.
- Also, there was a
related workshop on the Need for Increased Role of Genomics/Molecular
Medicine in the Medical Curriculum by two clinicians, Dr. Jay Ellison, Pediatrics/Genetics at
the Mayo Clinic, and Dr. Charles Weiner, Pulmonary/Respiratory
Medicine at Johns Hopkins University Medical School.
- A panel discussion by
representatives of the six basic science
disciplines on What is the role of molecular medicine in medical science
education? I was pleased to
represent Biochemistry on the panel discussion.
One important point arising from these discussions is the lack of
an appreciation for the role of molecular medicine in clinical medicine and how
it might be incorporated into the education of medical students. Below, I
have listed numerous citations of interest that relate to this topic and
document it clinical significance. We in B&MB have found these
citations to be very useful in introducing medical genomics to medical
students. I provide this very partial list as an information resource for
a discussion meeting I would like to hold latter in August or early in
September, 2004.
Websites with
links to some of these articles are also listed and our library has direct access
to the other cited journals.
- http://www.ornl.gov/sci/techresources/Human_Genome/medicine/medicine.shtml:
Medicine and the New Genetics: Human Genome Project Information
Review articles: (hotlinks to
#2-#13 can be found at http://content.nejm.org/misc/genmed.shtml)
- Genomics
as a Probe for Disease Biology Burke W. N Engl
J Med 2003; 349:969-72
- Cardiovascular
Disease Nabel E.G. N Engl J Med 2003; 349:60-72
- Breast
and Ovarian Cancer Wooster R., Weber B.L. N Engl J Med 2003;
348:2339-47
- Molecular
Diagnosis of the Hematologic Cancers Staudt L.M. N Engl J Med 2003;
348:1777-85
- Alzheimer's
Disease and Parkinson's Disease Nussbaum R.L., Ellis C.E. N Engl J Med 2003; 348:1356-64
- Hereditary
Colorectal Cancer Lynch H.T., de la Chapelle
A. N Engl J Med 2003; 349:919-32
- Drug
Therapy: Pharmacogenomics Drug Disposition,
Drug Targets, and Side Effects Evans W.E., McLeod H.L. N Engl J Med 2003; 348:538-49
- Inheritance
and Drug Response Weinshilboum R. N Engl J Med 2003; 348:529-36
- Population
Screening in the Age of Genomic Medicine Khoury M.J., McCabe
L.L., McCabe E.R.B. N Engl
J Med 2003; 348:50-8
- Genetic
Testing Burke W. N Engl J Med 2002;
347:1867-75
- Genomic
Medicine A Primer Guttmacher
A.E., Collins F.S. N Engl
J Med 2002; 347:1512-21
- Sounding
Board: The Charitable Trust as a Model for Genomic Biobanks
Winickoff
D.E., Winickoff R.N. N Engl J Med 2003; 349:1180-4
- Pharmacogenetics goes genomic Goldstein
D.B., Tate S.K., Sisodiya S.M. Nature Reviews - Genetics 2003;
4:937- 47
- Pharmacogenetics of cytochrome
P450 and its applications in drug therapy: the past, present and
future Ingelman-Sundberg M. Trends in Pharmacological . 2004; 25:193-200
- Pharmacogenetics: potential for
individualized drug therapy through genetics Johnson J.A.
Trends in Genetics 2003; 19:660-6
- Genetic
testing for cancer susceptibility: the promise and the pitfalls Lerman C., Shields A.E. Nature
Reviews - Cancer
2004; 4:235-41
Specific Diseases/Cancers:
- Pharmacogenetic Study of Statin
Therapy and Cholesterol Reduction Chasman et al. JAMA. 2004;291:2821-27
- Using Pharmacogenetics to Improve Drug Safety and Efficacy
S. Haga and W. Burke. JAMA. 2004; 291:2869-71
- A two-gene
expression ratio predicts clinical outcome in breast cancer patients
treated with tamoxifen Ma, X.J. et al. Cancer Cell 2004; 5:607-16
- Tamoxifen resistance by a
conformational arrest of the estrogen receptor α after PKA activation
in breast cancer. Michalides,
R. et al .
Cancer Cell
2004; 5:597-605
- Constitutional genetic
variation at the human aromatase gene (Cyp19)
and breast cancer risk Siegelmann-Danieli,N.;
Buetow,K.H. Br. J. Cancer 1999; 79:456-463
In addition, the site below is quite good for keeping one informed
of new genomic news in clinical medicine and is a good source for looking up
some past publications on these same items. This is another excellent
resource for putting molecular medicine into the basic science curriculum:
HOME PAGE: http://www.genomenewsnetwork.org/
or go to TOPICS http://www.genomenewsnetwork.org/categories/
For example, for an
interesting metabolism and cancer topic start from the HOME PAGE to
TOPICS to DISEASES to CANCER and select Predicting
Resistance to the Breast Cancer Drug Tamoxifen (10 Jun 2004) for a review of a citations 20 and 21
above.
For an example of an interesting physiological topic start from the
HOME PAGE to TOPICS to GENES AND GENOMES to GENE TESTS and
select "Physicians
Recommend Gene Test for Families with Hypertension (23 Jul 2004)" for a review of a paper from
American College of Chest Physicians, "Diagnosis and Management of
Pulmonary Arterial Hypertension." CHEST 126, Supplement (July 2004).